ФАКТОРЫ РИСКА РАЗВИТИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ

  • Н. С. Белюк УО "Гродненский государственный медицинский университет", Гродно, Беларусь
  • В. А. Снежицкий УО "Гродненский государственный медицинский университет", Гродно, Беларусь https://orcid.org/0000-0002-1706-1243
Ключевые слова: фибрилляция предсердий, факторы риска, профилактика

Аннотация

Фибрилляция предсердий – одна из самых распространенных сердечных аритмий, которая опасна своими осложнениями. В данной статье освещены наиболее часто встречающиеся факторы риска развития аритмии: ожирение, гипертензия, диабет, курение и другие. Анализ модифицируемых факторов риска позволит разработать профилактические меры, и тем самым снизить частоту встречаемости фибрилляции предсердий.

Литература

Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Larsen TB, Lip GY, Løchen ML, Marín F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR, Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE, Figueiredo M, et al. European Heart Rhythm Association (EHRA) / European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017;19:190-225. http://doi.org/10.1093/europace/euw242.

Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JHJr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-847. http://doi.org/10.1161/circulationaha.113.005.

Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, Van Gilst WH, Van Gelder IC, Rienstra M. Incidence of atrial fibrillation and relation with cardiovascular events, heart failure and mortality – a community-based study from the Netherlands. American College of Cardiology. 2015;66(9):1000-1007. http://doi.org/10.1016/j.jacc.2015.06.1314.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38):2893-2962. http://doi.org/10.1093/eurheartj/ehw.

Dublin S, Glazer NL, Smith NL, Psaty BM, Lumley T, Wiggins KL, Page RL, Heckbert SR. Diabetes mellitus, glycemic control, and risk of atrial fibrillation. Journal of General Internal Medicine. 2010;25(8):853-858. http://doi.org/10.1007/s11606-010-1340-y.

Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, Faber J, Hansen PR, Pedersen OD, TorpPedersen C, Gislason GH. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. British Medical Journal. 2012;345:e7895. http://doi.org/10.1136/bmj.e7895.

Chang SH, Wu LS, Chiou MJ, Liu JR, Yu KH, Kuo CF, Wen MS, Chen WJ, Yeh YH, See LC. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovascular Diabetology. 2014;13:123. http://doi.org/10.1186/s12933-014-0123-x.

Overvad TF, Skjøth F, Lip GYH, Lane DA, Albertsen IE, Rasmussen LH, Larsen TB. Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study. Stroke. 2015;46(8):2168-2174. http://doi.org/10.1161/STROKEAHA.115.009371.

Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, Twomey D, Elliott AD, Kalman JM, Abhayaratna WP, Lau DH, Sanders P. Long-term Effect of Goal-Directed Weight Management in an Atrial Fibrillation cohort: a long-term follow-up study (LEGACY). Journal of the American College of Cardiology. 2015;65(20):2159-2169. http://doi.org/10.1016/j.jacc.2015.03.002.

Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. Journal of the American College of Cardiology. 2013;62(4):300-305. http://doi.org/10.1016/j.jacc.2013.03.052.

Habibovic M, Versteeg H, Pelle AJ, Theuns DA, Jordaens L, Pedersen SS. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease. Europace. 2013;15(3):355-361. http://doi.org/10.1093/europace/eus295.

Whang W, Davidson KW, Conen D, Tedrow UB, Everett BM, Albert CM. Global psychological distress and risk of atrial fibrillation among women: The Women’s Health Study. Journal of the American Heart Association. 2012;1(3):e001107. http://doi.org/10.1161/JAHA.112.001107.

Andrade J, Khairy P, Dobrev D, Nattel S. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circulation Research. 2014;114(9):1453-1468. http://doi.org/10.1161/CIRCRESAHA.114.303211.

Brugger N, Krause R, Carlen F, Rimensberger C, Hille R, Steck H, Wilhelm M, Seiler C. Effect of lifetime endurance training on left atrial mechanical function and on the risk of atrial fibrillation. International Journal of Cardiology. 2014;170(3):419-425. http://doi.org/10.1016/j.ijcard.2013.11.032.

Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, Eberly LE, Alonso A. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm 2011;8(8):1160-1166. http://doi.org/10.1016/j.hrthm.2011.03.038.

Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, Alasady M, Hanley L, Antic NA, McEvoy RD, Kalman JM, Abhayaratna WP, Sanders P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. Journal of the American College of Cardiology. 2014;64(21):2222-2231. http://doi.org/10.1016/j.jacc.2014.09.028.

Caldeira D, Martins C, Alves LB, Pereira H, Ferreira JJ, Costa J. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart. 2013;99(19):1383-1389. http://doi.org/10.1136/heartjnl-2013-303950.

Di Rocco JR, During A, Morelli PJ, Heyden M, Biancaniello TA. Atrial fibrillation in healthy adolescents after highly caffeinated beverage consumption: two case reports. Journal of Medical Case Reports. 2011;5:18.

Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. Journal of the American College of Cardiology. 2014;64(3):281-289. http://doi.org/10.1016/j.jacc.2014.03.048.

Kaakeh Y, Overholser BR, Lopshire JC, Tisdale JE. Druginduced atrial fibrillation. Drugs. 2012;72(12):1617-1630. http://doi.org/10.2165/11633140-000000000-00000.




Загрузок PDF: 146
Опубликован
2021-05-12
Как цитировать
1.
Белюк НС, Снежицкий ВА. ФАКТОРЫ РИСКА РАЗВИТИЯ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ. Журнал ГрГМУ (Journal GrSMU) [Интернет]. 12 май 2021 г. [цитируется по 25 июль 2024 г.];18(1):73-8. доступно на: http://journal-grsmu.by/index.php/ojs/article/view/2569

Наиболее читаемые статьи этого автора (авторов)

1 2 > >>